Secondary pseudotumor cerebri syndrome following corticosteroid withdrawal is well a documented entity. Timely diagnosis is critical to preventing blindness. It can be particularly challenging to diagnose in very young children as they may not be able to verbalise the symptoms of headaches and visual loss. Additionally, there can be diagnostic uncertainty if there is subtle papilledema or clinical examination is difficult. Optical coherence tomography can be a very useful tool to both diagnose and monitor papilledema as demonstrated in this 4 year old child following steroid withdrawal for severe eczema. The authors also aim to highlight the importance of the multidisciplinary team in successful management of these challenging cases.
INTRODUCTION
Secondary pseudotumor cerebri syndrome is well documented with risk factors inclusive of tetracyclines, retinoids, corticosteroid, growth hormone withdrawal and renal diseases (1) (2) (3) (4) (5) .
The revised criteria by Friedman et al aims to improve the diagnostic sensitivity and specificity in both adults and paediatric patients (1, 6) . Early diagnosis is pivotal as the rates for permanent visual impairment varies from 10-40% [Table 1 ] (7, 8) . This can be challenging in very young patients as they may not be able to verbalise the symptoms of headaches and visual loss. Additionally, there can be diagnostic uncertainty if there is subtle papilledema or clinical examination is difficult; modern ophthalmic imaging can be a useful objective tool in these patients.
The authors would like to present a 4yr old boy with severe eczema treated with intramuscular triamcinolone injections for over 1yr, who was diagnosed with secondary pseudotumor cerebri syndrome, failure to thrive and uncontrolled eczema. Optical coherence tomography was used to successfully guide the diagnostic and therapeutic challenges of this clinical scenario (9, 10) .
CASE REPORT
A 4yr old boy was referred by the optician for headaches over the past month. He was unfortunately treated by a general practitioner for severe eczema with weekly intramuscular triamcinolone 40mg for one month, followed by monthly intramuscular triamcinolone 40mg for a subsequent fourteen months (Fig 1) . He was also on oral anti-histamine and topical antifungal creams. The last injection was two months prior to the presentation. He was below the fifth centile for his age: height 11.3kg and weight 95cm.
Ophthalmic examination was as follows: Snellen visual acuity 6.75 both eyes (BE), refraction +0.25DS BE; intraocular pressures were 16mmHg Goldmann's tonometry (BE); dilated fundoscopy, fundus photography and optical coherence imaging (OCT) showed elevated nerve fibre layer confirmed Frisén papilledema grade 1 in the right eye and grade 2 in the left eye (Fig 2) .
The child was referred to the paediatric accident and emergency and admitted. He was subsequently managed by a multidisciplinary team inclusive of ophthalmologist, paediatrician, dermatologist and neurologist. Secondary intracranial hypertension was confirmed with a lumbar puncture, normal CSF cytology; MRI (magnetic resonance imaging) of the head showed distension of optic nerve sheaths with flattened macula. He was successfully managed with oral acetazolamide (Fig 3) .
The severe, rebound erythrodermic eczema was treated with oral azathioprine 2-3mg/kg, intensive moisturisers, dry wrapping and topical pimecrolimus to the face in a subsequent prolonged inpatient stay. There was concern by the ophthalmologist that further topical/oral corticosteroids may exacerbate the secondary pseudotumor cerebri. A report was sent to the local regulatory body as per good clinical practice.
The child was reviewed monthly by the ophthalmologist over the past year. OCT showed clear consistent response to the acetazolamide (Fig 4) . The headaches have resolved, there is charted growth and control of the eczema (Fig 1) with a significant improvement in the child's quality of life.
DISCUSSION
Idiopathic intracranial hypertension or pseudotumor cerebri is an entity of ill-defined etiology. It is characterised by raised intracranial hypertension, normal CSF biochemistry and normal neuroimaging (Table 1) . Secondary pseudotumor cerebri (SPC) is a subset within which specific medical conditions and pharmacological associations have been documented.
Corticosteroid withdrawal is a well-known feature (3) (4) (5) . Interestingly, adrenal hormones are 4 important for activation and trophic effects on cell survival, differentiation, maturation and synaptogenesis of the central nervous system. It is therefore not surprising that various exogenous and endogenous disorders of the hypothalamic-pituitary-axis lead to SPC (11) .
The commonest presenting feature is headaches; 90% presents with headaches, 62% with transient visual loss and 52% with transient tinnitus. In children the most consistent features are headaches and visual loss as it is difficult for children to verbalise the symptoms (12) . Notably, patients with pseudotumor cerebri have several deficits in cognitive function such as patients, including memory, executive function, visual-spatial processing, attention, motor skills, working memory, and processing speed; these can persist up to three months despite successful reduction in the intracranial pressures (12) . Table 1 Diagnostic criteria for pseudotumor cerebri syndrome 6 1 Required for diagnosis of pseudotumor cerebri syndrome a A. Papilledema B. Normal neurologic examination except for cranial nerve abnormalities C. Neuroimaging: Normal brain parenchyma without evidence of hydrocephalus, mass, or structural lesion and no abnormal meningeal enhancement on MRI, with and without gadolinium, for typical patients (female and obese), and MRI, with and without gadolinium, and magnetic resonance venography for other; if MRI is unavailable or contraindicates, contrast-enhanced CT may be used D. Normal CSF composition E. Elevated lumbar puncture opening pressure (≥250mm CSF in adults and ≥280mm CSF in children [250mm CSF if the child is not sedated and not obese] in a properly performed lumber puncture 2 Diagnosis of pseudotumor cerebri syndrome without papilledema In the absence of papilledema, a diagnosis of pseudotumor cerebri syndrome can be made if B-E from above are satisfied, and in addition the patient has a unilateral or bilateral abducens of nerve palsy
In the absence of papilledema or sixth nerve palsy, a diagnosis of pseudotumor cerebri syndrome can be suggested but not made if B_E from above are satisfied, and in addition at least 3 of the following neuroimaging criteria are satisfied i. Empty Sella ii. Flattening of the posterior aspect of the globe iii. Distention of the perioptic subarachnoid space with or without a tortuous optic nerve iv.
Transverse venous sinus stenosis a A diagnosis of pseudotumor cerebri syndrome is definite if the patient fulfils criteria A-E. The diagnosis is considered probable if criteria A-D are met but the measured CSF pressure is lower than specified for a definite diagnosis. 
